Men's Basic Prevention Panel

IFCOR's Men's Basic Prevention panel adds PSA (prostate-specific antigen) to the core preventive markers, making it the standard starting point for men's annual health monitoring. PSA alongside CBC, lipid profile, liver enzymes, kidney function, CRP, and urinalysis gives a clinically meaningful cross-section of the health risks men face from their 40s onward. At 1,050 Kč total, it is priced to make annual monitoring accessible without needing a GP referral or health insurance coverage. The panel requires a standard fasting blood draw and morning urine, with results available the next business day by secure email from the ISO 15189-accredited Jihlava laboratory.

The Men's Basic Prevention panel is a 20-biomarker screen that parallels the Women's Basic panel while including PSA in place of TSH, reflecting the different sex-specific risk profile. PSA (prostate-specific antigen) is a serine protease produced by prostate cells and released into the bloodstream; elevated levels can indicate benign prostate hyperplasia, prostatitis, or prostate cancer, and the Men's Basic panel is the front-line tool for monitoring this risk from the age of 45–50 onward. The test also covers: complete blood count with differential, which detects anaemia, infection, and platelet disorders; sodium, potassium, and chloride electrolytes for kidney and hydration assessment; fasting glucose to screen for insulin resistance and type 2 diabetes, which carries a higher risk burden for men who are overweight or sedentary; the full cardiovascular lipid panel (total cholesterol, LDL, HDL, triglycerides) critical for cardiovascular risk estimation in men, whose event rates are higher than women's before the age of 65; liver enzyme panel (ALT, AST, GGT, ALP) for hepatic health monitoring, particularly relevant for men who consume alcohol or take long-term medications; bilirubin for bile flow assessment; urea and creatinine for kidney filtration; CRP for systemic inflammation; uric acid for gout and metabolic syndrome risk; and urinalysis with sediment. Collection requires fasting blood draw plus morning urine. Important PSA preparation: avoid rectal examination, cystoscopy, or catheterisation for 48 hours before the test, do not cycle for 24 hours prior, and wait at least two weeks after a prostate biopsy. Results are delivered by secure email the next business day with no GP referral needed.